Skip to main content

Kosten News Blog

Stay up to date with what's going on with Kosten Foundation

Kosten Foundation’s 10th Annual Kick It 5K Going Virtual

Memphis, Tenn., September 1, 2020 – The Kosten Foundation has announced its 10th annual Kick It 5K will now be a virtual event hosted November 5-19 during Pancreatic Cancer Awareness Month. The walk/run fundraiser has been rescheduled from April due to COVID-19 and rescheduled again from October to the final dates of November 5-19 to align with Pancreatic Cancer Awareness Month.

Out of an abundance of caution, the Kosten Foundation is making the 5K a virtual event in November. Participants can now sign up to run or walk the virtual Kick It 5K and/or donate to help fight Pancreatic Cancer and support those fighting the disease at this link Those interested can also visit for more information.

Participants can now social distance and either run or walk their 5K wherever they want over a two-week period. Runners, walkers, and supporters that signed up during the earlier registration periods will have their registrations carried over to the new date.

“As always, the most important thing to us is the safety of our participants and pancreatic cancer survivors. While postponing our April event was not ideal, we are excited to be able to host a virtual event this year where participants can participate by running or walking in their own neighborhoods or wherever they desire during Pancreatic Cancer Awareness Month November 5 – 19,” said Alan Kosten, Chairman of the Kosten Foundation. “This is our largest fundraiser of the year, so we are asking everyone to join in and please help support the fight against Pancreatic Cancer by running, walking or donating to the Kick It 5K today.”

Over the last 17 years, the Kosten Foundation has raised more than $2 million for research, awareness, and support against pancreatic cancer. The Kick It 5K is the organization’s largest fundraiser for the cause.

Make A Donation

Your donation funds our research, support group, symposium series and other valuable projects in our efforts to end pancreatic cancer and to support those touched by the disease.